Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

Objective The objective of this study was to report the incidence of uveitis in secukinumab‐treated patients with ankylosing spondylitis (AS) in a pooled analysis of three phase 3 trials (MEASURE 1‐3 [ClinicalTrials.gov identifiers NCT01358175, NCT01649375, NCT02008916]). Methods Analysis included p...

Full description

Bibliographic Details
Main Authors: Atul A. Deodhar, Corine Miceli‐Richard, Xenofon Baraliakos, Helena Marzo‐Ortega, Dafna D. Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi Jr, Brian Porter, Abhijit Shete, James T. Rosenbaum
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11139

Internet

https://doi.org/10.1002/acr2.11139

Similar Items